124 related articles for article (PubMed ID: 34840225)
1. Tac2-N Promotes Glioma Proliferation and Indicates Poor Clinical Outcomes.
Dou Y; Xu H; Wu X; Liu P
Tohoku J Exp Med; 2021 Nov; 255(3):247-256. PubMed ID: 34840225
[TBL] [Abstract][Full Text] [Related]
2. Yippee Like 1 Suppresses Glioma Progression and Serves as a Novel Prognostic Factor.
Li W; Huang W; Wu K; Long Y
Tohoku J Exp Med; 2022 Feb; 256(2):141-150. PubMed ID: 35185081
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many Cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract][Full Text] [Related]
4. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of TC2N is associated with poor prognosis in gastric cancer.
Xu J; Ou X; Li J; Cai Q; Sun K; Ye J; Peng J
J Cancer; 2021; 12(3):807-817. PubMed ID: 33403038
[No Abstract] [Full Text] [Related]
6. TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer.
Hao XL; Han F; Zhang N; Chen HQ; Jiang X; Yin L; Liu WB; Wang DD; Chen JP; Cui ZH; Ao L; Cao J; Liu JY
Cell Death Differ; 2019 Jul; 26(7):1235-1250. PubMed ID: 30254375
[TBL] [Abstract][Full Text] [Related]
7. S100A11 Promotes Glioma Cell Proliferation and Predicts Grade-Correlated Unfavorable Prognosis.
Wang H; Yin M; Ye L; Gao P; Mao X; Tian X; Xu Z; Dai X; Cheng H
Technol Cancer Res Treat; 2021; 20():15330338211011961. PubMed ID: 33902363
[TBL] [Abstract][Full Text] [Related]
8. Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.
Li M; Li X; Xu S; Xue P; Li Q; Lu Q; Jia Q; Zhang L; Li X; Li X
Tumour Biol; 2016 Sep; 37(9):11893-11901. PubMed ID: 27059736
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
10. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
Chen XD; Zhu MX; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
[TBL] [Abstract][Full Text] [Related]
11. CDCA7L promotes glioma proliferation by targeting CCND1 and predicts an unfavorable prognosis.
Ji QK; Ma JW; Liu RH; Li XS; Shen FZ; Huang LY; Hui L; Ma YJ; Jin BZ
Mol Med Rep; 2019 Aug; 20(2):1149-1156. PubMed ID: 31173217
[TBL] [Abstract][Full Text] [Related]
12. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
[TBL] [Abstract][Full Text] [Related]
13. Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker.
Liu D; Wang X; Liu Y; Li C; Zhang Z; Lv P
Dis Markers; 2022; 2022():9516808. PubMed ID: 36583064
[TBL] [Abstract][Full Text] [Related]
14. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
Zhao W; Sun C; Cui Z
Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
[TBL] [Abstract][Full Text] [Related]
15. TUBA1C expression promotes proliferation by regulating the cell cycle and indicates poor prognosis in glioma.
Gui S; Chen P; Liu Y; Chen Q; Cheng T; Lv S; Zhou T; Song Z; Xiao J; He W; Yuan S; Cheng Z
Biochem Biophys Res Commun; 2021 Nov; 577():130-138. PubMed ID: 34517210
[TBL] [Abstract][Full Text] [Related]
16. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
17. Tac2-N serves an oncogenic role and promotes drug resistance in human gastric cancer cells.
Shen L; Zhang P; Wang J; Ji P
Exp Ther Med; 2020 Nov; 20(5):113. PubMed ID: 32989391
[TBL] [Abstract][Full Text] [Related]
18. TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas.
Han MZ; Xu R; Xu YY; Zhang X; Ni SL; Huang B; Chen AJ; Wei YZ; Wang S; Li WJ; Zhang Q; Li G; Li XG; Wang J
J Exp Clin Cancer Res; 2017 Nov; 36(1):155. PubMed ID: 29110682
[TBL] [Abstract][Full Text] [Related]
19. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
20. Expression of long non-coding RNA CRNDE in glioma and its correlation with tumor progression and patient survival.
Jing SY; Lu YY; Yang JK; Deng WY; Zhou Q; Jiao BH
Eur Rev Med Pharmacol Sci; 2016 Oct; 20(19):3992-3996. PubMed ID: 27775801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
